- 作者：I. Mollet ; isabelle.mollet@efs.sante.fr ; C. Giannoli ; D. Rigal ; V. Dubois
- 关键词：Greffe de cellules souches hé ; matopoï ; é ; tiques ; Chimé ; risme ; Chimé ; risme mixte ; Rechute ; Cellules myé ; loï ; des ; Cellules lymphoï ; des ; Quantification en temps ré ; el
- 刊名：Pathologie Biologie
- 出版年：2012
- 期刊代码：216_03698114
- 类别：med
- 出版时间：April, 2012
- 卷：60
- 期：2
- 页码：143-148
- 文件大小：1092 K
Haematopoietic stem cells transplantation, widely used these last decades, represent the ultimate treatment resource for patients with haematological malignancies. Long range success of this treatment is particularly affected by relapse of the initial disease, graft rejection or graft versus host disease. Chimerism analysis after transplantation had been used since several years to document engraftment, to determine the risk of relapse and to adapt therapy promptly when necessary. Usefulness of this analysis for the outcome of transplanted patients, as well as the impact of using high sensitive techniques coupled with specific cell populations sorted have been demonstrated by retrospective studies. Follow-up of chimerism would allow to operate efficiently before the onset of clinical signs in leukaemic patients with high risk of relapse and to control the expression of minimal residual disease when specific molecular markers could not be monitored.